Skip to main content
. 2021 Jun 24;147(8):739–743. doi: 10.1001/jamaoto.2021.1259

Table 1. Characteristics of Patients With New-Onset Peripheral Facial Nerve Palsy After Recent Vaccination With the BNT162b2 (Pfizer-BioNTech) Vaccine.

Patient No. Comorbidities Laterality HB gradea Status at last follow-up
1 None Right IV Partially recovered
2 None Right NA Partially recovered
3 Dyslipidemia Left IV NA
4 Hypertension Left IV NA
5 Hypertension, prostate cancer Left NA NA
6 None Right NA NA
7 Cardiac pacemaker Left VI Partially recovered
8 Dyslipidemia Right IV NA
9 Hypertension, OSA, cochlear Ménière disease Left III Partially recovered
10 None Right III Partially recovered
11 None Right NA Partially recovered
12 Hepatitis C Right NA NA
13 Dyslipidemia, hypothyroidism, thalassemia Right III NA
14 Hypertension, BPH, diabetes Right NA NA
15 Asthma Right NA Partially recovered
16 None Right II NA
17 None Left III Partially recovered
18 Small fiber neuropathy Right IV Partially recovered
19 Diabetes Right III NA
20 None Left III NA
21 None Left NA NA

Abbreviations: BPH, benign prostatic hyperplasia; HB, House-Brackmann; NA, not available; OSA, obstructive sleep apnea.

a

Obtained at admission. Scores range from I to VI, with higher scores indicating severe nerve damage.